Patellofemoral Osteoarthritis Clinical Trial
Official title:
THE USE OF FRESH PRP VS HA IN THE TREATMENT OF OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT Randomized Controlled Clinical Trial
NCT number | NCT04937998 |
Other study ID # | PRP-21 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 26, 2022 |
Est. completion date | October 2024 |
The aim of the study is to compare the 12-month clinical outcomes of patients with patellofemoral osteoarthritis undergoing infiltrative treatment with fresh PRP and HA
Status | Recruiting |
Enrollment | 166 |
Est. completion date | October 2024 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Age between 30 and 65; 2. Signs and symptoms of isolated patellofemoral osteoarthritis present in one or both knees; 3. Radiographic signs of isolated patellofemoral osteoarthritis (according to Iwano et al stage 1-3 classification) or chondropathy (assessed on MRI) with K-L grade of the other compartments = 2. [PMID: 2302884 - PMID: 27979409] ; 4. Hemoglobin > 11 g/dl; Platelet count > 150,000 plt/mm3 (Recently performed CBC exam); 5. No clinically significant electrocardiographic alterations (Recently performed ECG). 6. Ability and consent of patients to actively participate in clinical follow-up; 7. Signature of informed consent. Exclusion Criteria: 1. Patients unable to express consent; 2. Patients who have undergone intra-articular infiltration of another substance within the previous 6 months; 3. Patients undergoing knee surgery within the previous 12 months; 4. Patients with malignant neoplasms; 5. Patients with rheumatic diseases; 6. Patients with diabetes; 7. Patients with hematologic diseases (coagulopathies); 8. Patients on anticoagulant-antiaggregant therapy; 9. Patients with thyroid metabolic disorders; 10. Patients abusing alcoholic beverages, drugs or medications; 11. Body Mass Index > 35; 12. Patients who have taken NSAIDs in the 3 days prior to blood draw; 13. Patients with cardiovascular disease for which a 60 mL blood draw would be contraindicated; 14. Patients with a recently performed blood test with Hb< 11 g/dl and Platelets < 150,000 plt/mm3. 15. Previous treatment of patellar dislocation 16. Iwano score of grade 4. |
Country | Name | City | State |
---|---|---|---|
Italy | Istituto Ortopedico Rizzoli | Bologna |
Lead Sponsor | Collaborator |
---|---|
Istituto Ortopedico Rizzoli |
Italy,
Assirelli E, Filardo G, Mariani E, Kon E, Roffi A, Vaccaro F, Marcacci M, Facchini A, Pulsatelli L. Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surg Sports Traumatol Arthrosc. 2015 Sep;23(9):2690-703. doi: 10.1007/s00167-014-3113-3. Epub 2014 Jun 19. — View Citation
Cavallo C, Filardo G, Mariani E, Kon E, Marcacci M, Pereira Ruiz MT, Facchini A, Grigolo B. Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg Am. 2014 Mar 5;96(5):423-9. doi: 10.2106/JBJS.M.00726. — View Citation
deDeugd CM, Pareek A, Krych AJ, Cummings NM, Dahm DL. Outcomes of Patellofemoral Arthroplasty Based on Radiographic Severity. J Arthroplasty. 2017 Apr;32(4):1137-1142. doi: 10.1016/j.arth.2016.11.006. Epub 2016 Nov 15. — View Citation
Di Martino A, Di Matteo B, Papio T, Tentoni F, Selleri F, Cenacchi A, Kon E, Filardo G. Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial. Am J Sports Med. 2019 Feb;47(2):347-354. doi: 10.1177/0363546518814532. Epub 2018 Dec 13. — View Citation
Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol. 2006 Jun;38(2):174-87. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | KOOS-Pain Score | KOOS-Pain Score is referred to a subscale of pain composed by 9 items. The score range considerate is 0-100.The score uses a 5-point Likert scale and each question is assigned a score from 0 to 4, where 0 indicates "no pain" and 4 "severe level of pain". | 12 months | |
Secondary | IKDC-Subjective Score | This is a subjective, knee-specific rating scale that is considered one of the most reliable assessment tools in the evaluation of knee pathologies. All questions examines 3 categories: symptoms, sports activity, and knee function. | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | KOOS-Pain Score | KOOS-Pain Score is referred to a subscale of pain composed by 9 items. The score range considerate is 0-100.The score uses a 5-point Likert scale and each question is assigned a score from 0 to 4, where 0 indicates "no pain" and 4 "severe level of pain". | baseline, 2 month, 6 months , 24 months follow-up | |
Secondary | Visual Analogue Scale (VAS) | VAS is a visual analogue scale consisting of a range scale (10 cm length), the ends of which correspond to "no pain" and "the strongest pain imaginable". | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | EQ-VAS | EQ-VAS Is a visual analog scale that has a range of scores from 0 (worst imaginable health condition) to 100 (best imaginable health condition). | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | EQ-5D (EuroQoL) Current Health Assessment | EQ-5D is useful to evaluate the quality life of the patients | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | Tegner Activity Level Scale | Tegner activity level scale allows to know the level of physical activity carried out by the patients. All patients will indicate the type of sporting activity performed and its frequency. | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | Objective parameters- Range of Motion | Evaluation of the Range of Motion for comparative analysis. | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | Objective parameters - Circumferences | Bilateral trans- and supra- patellar circumferences measurement for comparative analysis | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | Patient Acceptable Symptom State (PASS) | A tool to assess patient satisfaction in consideration of their current degree of pain, function, and daily activity. Patients can express if their state of health will be satisfying, answering "yes" or "no. | baseline, 2 month, 6 months, 12 months , 24 months follow-up | |
Secondary | The Kujala Anterior Knee Pain Scale (AKPS) | It's a 100-point scale consisting of 13 items with a score ranging from 5 to 10 points per item. A score of 0 points indicates the most severe limitation, while a score of 100 points indicates a normal situation. | baseline, 2 month, 6 months, 12 months , 24 months follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06060730 -
Measurement Properties of the Turkish Version of the Patellofemoral Pain and Osteoarthritis Subscale of the KOOS
|
||
Completed |
NCT02825238 -
Effect of Hip and Core Muscle Strengthening for Patellofemoral Osteoarthritis: A Feasibility Study
|
N/A | |
Completed |
NCT03281837 -
2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)
|
N/A | |
Completed |
NCT05184439 -
Evaluation of Adductor Magnus Tenodesis in Patients With Recurrent Patellar Dislocation.
|
||
Not yet recruiting |
NCT04332900 -
Proximal and Distal Therapeutic Approach in Pain and Lower Limb Kinematic in People With Patellofemoral Osteoarthritis
|
N/A | |
Completed |
NCT02610192 -
nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis
|
N/A | |
Recruiting |
NCT06163573 -
Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.
|
Phase 2 | |
Completed |
NCT04589871 -
Taping Technique With Supervised Exercises Protocol on Pain and Functional Status in Individuals With Arthritis
|
N/A | |
Active, not recruiting |
NCT04817969 -
Persona Ti-Nidium Post-Market Clinical Follow-up
|
N/A | |
Active, not recruiting |
NCT04772625 -
Failure Analysis of Patellofemoral Arthroplasty
|
||
Terminated |
NCT00816647 -
A Prospective Randomized Study of Medial Patellofemoral Ligament (MPFL) Reconstruction
|
N/A |